Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold
Zachary A. Knight(Howard Hughes Medical Institute), Kevan M. Shokat(Howard Hughes Medical Institute), Caroline B. Ho(Pfizer (United States)), Denise M. Kenski(University of California, San Francisco), Gary G. Chiang(Therapeutics Clinical Research), Kristin Coan(University of California, San Francisco), Peter J. Alaimo(Lawrence Berkeley National Laboratory), Robert T. Abraham(Sanford Burnham Prebys Medical Discovery Institute)
Cited by 136
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
Cell cycle checkpoint signaling through the ATM and ATR kinases
|Genes & Development|2001|2k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k